Monitoring Off-Label Medication Use in Children
Author Information
Author(s): Julie M Zito, Albert T Derivan, Christopher J Kratochvil, Daniel J Safer, Joerg M Fegert, Laurece L Greenhill
Primary Institution: University of Maryland, Baltimore, Maryland, USA
Hypothesis
Is close clinical monitoring necessary for off-label psychopharmacologic prescribing in children?
Conclusion
The study emphasizes the need for systematic clinical monitoring to ensure the safety of off-label psychotropic medications in children.
Supporting Evidence
- Off-label use of medications in pediatrics is common, representing 50-75% of pediatric medication use.
- Historical examples show that off-label medications can have serious adverse effects that were not initially recognized.
- Clinical monitoring is essential to minimize risks associated with off-label medication use in children.
Takeaway
Doctors often use medications for kids that aren't officially approved for them, so it's really important to keep a close eye on how these drugs affect them.
Methodology
The review analyzes historical data and clinical practices regarding off-label medication use in pediatric psychiatry.
Potential Biases
Potential bias in the interpretation of historical data and anecdotal evidence.
Limitations
The review is based on historical data and may not reflect current practices or all potential risks.
Participant Demographics
Focuses on children and adolescents, particularly those receiving off-label psychotropic medications.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website